These findings have important implications for understanding the underlying mechanisms of inflammation in obesity and SLE and may guide future research towards interventions that modulate IL-6 as a strategy to reduce systemic inflammation in high-BMI individuals. Here, IL6 is linked to obesity due to melanocortin 4 receptor deficiency.